Drug Discovery Overview
Our Drug Discovery Division includes nationally-recognized laboratories with expertise in both experimental and computional approaches to drug discovery, drug design, and drug responses. Projects include the development of anti-cancer agents, anti-inflammatory drugs, anti-thrombotic drugs, novel opiate analgesics, anti-convulsants, anti-Alzheimer and anti-Parkinson drugs, agents for the treatment of alcohol, tobacco, and psychostimulant abuse, neuroprotective agents, and drugs that interact with nicotinic receptors. Outstanding fundamental research is also underway to understand cell signaling pathways and to develop strategies to correct signaling defects that cause disease.